🔬 Peptide Research Blog

Latest studies, clinical trials, and scientific discoveries in peptide research

⚠️
Safety & Regulations January 5, 2025 9 min read

FDA Issues Warning on Compounded GLP-1 Agonists

The FDA warns about safety risks associated with compounded semaglutide and tirzepatide, including reports of adverse events from improperly formulated products. What researchers need to know about sourcing quality peptides.

Read More →